BAXFENDY

This brand name is authorized in United States.

Active ingredients

The drug BAXFENDY contains one active pharmaceutical ingredient (API):

1	Baxdrostat UNII NF3P9Z8J5Y - BAXDROSTAT
	Baxdrostat is an inhibitor of human aldosterone synthase. Aldosterone contributes to hypertension by promoting the retention of sodium and water by the kidneys, which increases blood volume and, consequently, raises blood pressure. Aldosterone can cause vascular dysfunction, inflammation, and fibrosis. Inhibition of aldosterone synthase by baxdrostat decreases plasma aldosterone concentrations, thereby reducing blood pressure.
	Read more about Baxdrostat

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BAXFENDY Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02KN02		C Cardiovascular system → C02 Antihypertensives → C02K Other antihypertensives → C02KN Other antihypertensives
Discover more medicines within C02KN02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	0310-6001, 0310-6002